Versant Venture Management as of June 30, 2020
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 12 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Stock (CRSP) | 44.2 | $307M | 4.2M | 73.49 | |
| Adverum Biotechnologies Common Stock | 21.0 | $146M | 7.0M | 20.88 | |
| Aprea Therapeutics Common Stock | 10.3 | $72M | 1.9M | 38.78 | |
| Akero Therapeutics Common Stock (AKRO) | 7.6 | $53M | 2.1M | 24.92 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 5.1 | $36M | 2.0M | 17.52 | |
| Veracyte Common Stock (VCYT) | 4.5 | $31M | 1.2M | 25.90 | |
| Gritstone Oncology Common Stock (GRTS) | 3.0 | $21M | 3.1M | 6.64 | |
| Ocular Therapeutix Common Stock (OCUL) | 2.7 | $19M | 2.2M | 8.33 | |
| IVERIC bio Common Stock | 1.3 | $8.8M | 1.7M | 5.10 | |
| CymaBay Therapeutics Common Stock | 0.3 | $1.9M | 544k | 3.49 | |
| Clovis Oncology Common Stock | 0.1 | $688k | 102k | 6.75 | |
| Second Sight Medical Products Common Stock | 0.1 | $550k | 562k | 0.98 |
